VIVIANE

Dear all,


Please , Can anyone sent me the percentage of the women HER2 - positivity who had been exposed to Herceptin in adjuvant treatment and developped reccurence after ?

From SABCS (Saint Antonio Breast Cancer )HERA study The break down of risk for relaspe in 2 yr. is as follows for observation group :

ER,PR Negative, her2+
Node Negative 18%
1-3 nodes 25%
greater 4 nodes 33%

ER,PR positive, her2+
Node Negative 9%
1-3 Nodes 12%
greater 4 nodes 33%


but I d'ont find anyting for the group one year herceptin .


I look forward to your prompt reply ,
Thank you for your cooperation ..
Sincerely,
VIVIANE